Teva Plans Action After Losing Opioids Trial In New York
Israeli Firm Is Preparing ‘Swift’ Appeal And Continues To Pursue A Mistrial
Following a mammoth six-month trial, a jury in New York has issued a verdict finding that Teva and some of its affiliates are liable for the public nuisance charges made by New York state in its opioid trial in Suffolk County State Supreme Court.
You may also be interested in...
In 2021, courts across the US and beyond continued to weigh key patent litigation fights, alongside the thorny issue of induced infringement via label carve outs and controversial charges for generic price fixing.
Following a recent settlement in Louisiana, Teva has been told by a court in California it is not liable for the state’s opioid crisis, avoiding for now the potential for significant damages.
Teva underlined that it was open to further individual state settlements in its broad and sweeping opioid litigation after reaching a deal with the Louisiana Attorney General's office.